Elite in Telangiectasia

Sophie Girod-Dupuis

Hospices Civils De Lyon
Bron, FR 
Elite in Telangiectasia
Hospices Civils De Lyon
Bron, FR 
OverviewLocationsClinical Research

Overview

Sophie Girod-Dupuis practices in Bron, France. Ms. Girod-Dupuis is rated as an Elite expert by MediFind in the treatment of Telangiectasia. Her top areas of expertise are Hereditary Hemorrhagic Telangiectasia, Telangiectasia, Pulmonary Arteriovenous Malformation (PAVM), and Arteriovenous Malformation.

Her clinical research consists of co-authoring 101 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 69 articles and participated in 2 clinical trials in the study of Telangiectasia.

Gender
Female

Locations

Hospices Civils de Lyon
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Enrollment Status: Completed
Publish Date: August 08, 2025
Intervention Type: Drug
Study Phase: Phase 2
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
Enrollment Status: Completed
Publish Date: August 06, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

101 Total Publications

Loss of function variants in ADAMTS6 : Connective tissue, Heart defect, thoracic Aortic aneurysm and Neuro developmental Syndrome (CHANS).
Loss of function variants in ADAMTS6 : Connective tissue, Heart defect, thoracic Aortic aneurysm and Neuro developmental Syndrome (CHANS).
Journal: medRxiv : the preprint server for health sciences
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Girod-Dupuis's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile